AR-12286
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for AR-12286, covering 2014-04-21 to 2023-08-22. Get the full timeline:
Most recent: Clinical Trial Update: A Study Assessing the Safety and Ocular Hypotensive Efficacy of AR-12286 in Patients With Elevated Intraocular Pressure for 3 Months [Phase 2]